Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Parkinson's Disease

  Free Subscription


02.04.2018

1 Ann Neurol
1 J Clin Pharmacol
1 J Neural Transm (Vienna)
14 Mov Disord
1 Neurobiol Dis
2 Neurochem Res
3 Neurology
4 Neurosci Lett
2 Neuroscience


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. JONIKAS M, Madill M, Mathy A, Zekoll T, et al
    Stem Cell modeling of Mitochondrial Parkinsonism reveals key functions of OPA1.
    Ann Neurol. 2018 Mar 31. doi: 10.1002/ana.25221.
    PubMed     Text format     Abstract available


    J Clin Pharmacol

  2. SAMPAIO TF, Dos Santos EUD, de Lima GDC, Dos Anjos RSG, et al
    MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
    J Clin Pharmacol. 2018 Mar 26. doi: 10.1002/jcph.1096.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  3. RIEDERER P, Muller T
    Monoamine oxidase-B inhibitors in the treatment of Parkinson's disease: clinical-pharmacological aspects.
    J Neural Transm (Vienna). 2018 Mar 22. pii: 10.1007/s00702-018-1876.
    PubMed     Text format     Abstract available


    Mov Disord

  4. SIMUNI T, Siderowf A, Lasch S, Coffey CS, et al
    Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort.
    Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27361.
    PubMed     Text format     Abstract available

  5. FOX SH, Katzenschlager R, Lim SY, Barton B, et al
    International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.
    Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27372.
    PubMed     Text format     Abstract available

  6. FASANO A, De Vloo P, Llinas M, Hlasny E, et al
    Magnetic resonance imaging-guided focused ultrasound thalamotomy in Parkinson tremor: Reoperation after benefit decay.
    Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27348.
    PubMed     Text format    

  7. ANTONINI A, Moro E, Godeiro C, Reichmann H, et al
    Medical and surgical management of advanced Parkinson's disease.
    Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27340.
    PubMed     Text format     Abstract available

  8. FERNANDEZ HH, Boyd JT, Fung VSC, Lew MF, et al
    Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
    Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27338.
    PubMed     Text format     Abstract available

  9. HEINZEL S, Kasten M, Behnke S, Vollstedt EJ, et al
    Age- and sex-related heterogeneity in prodromal Parkinson's disease.
    Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27349.
    PubMed     Text format    

  10. HOUSER MC, Chang J, Factor SA, Molho ES, et al
    Stool immune profiles evince gastrointestinal inflammation in Parkinson's disease.
    Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27326.
    PubMed     Text format     Abstract available

  11. MOGHADDAM HS, Arabi MH
    Synaptotagmin-11 Is a novel hotspot in the pathogenesis of parkin-linked Parkinson's disease: New implications for clinical targeting.
    Mov Disord. 2018 Mar 24. doi: 10.1002/mds.27369.
    PubMed     Text format    

  12. KADHIM S, Pringsheim T, Le A, Fiest KM, et al
    Validating screening tools for depression in Parkinson's disease.
    Mov Disord. 2018 Mar 24. doi: 10.1002/mds.27371.
    PubMed     Text format    

  13. LITVAN I, Kieburtz K, Troster AI, Aarsland D, et al
    Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment.
    Mov Disord. 2018 Mar 24. doi: 10.1002/mds.27345.
    PubMed     Text format     Abstract available

  14. COSSU G, Melis M, Sarchioto M, Melis M, et al
    6-n-propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's disease.
    Mov Disord. 2018 Mar 24. doi: 10.1002/mds.27391.
    PubMed     Text format     Abstract available

  15. KORDOWER JH, Burke RE
    Disease modification for Parkinson's disease: Axonal regeneration and trophic factors.
    Mov Disord. 2018 Mar 30. doi: 10.1002/mds.27383.
    PubMed     Text format     Abstract available

  16. WEIR S, Samnaliev M, Kuo TC, Tierney TS, et al
    Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.
    Mov Disord. 2018 Mar 30. doi: 10.1002/mds.27302.
    PubMed     Text format     Abstract available

  17. MACEROLLO A, Brown MJN
    Beta oscillations and indirect pathway spiny projecting neurons: A selective neuronal mechanism linked to Parkinsonian pathophysiology?
    Mov Disord. 2018 Mar 30. doi: 10.1002/mds.27388.
    PubMed     Text format    


    Neurobiol Dis

  18. GLEAVE JA, Arathoon LR, Trinh D, Lizal KE, et al
    Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146].
    Neurobiol Dis. 2018 Mar 20. pii: S0969-9961(18)30054.
    PubMed     Text format    


    Neurochem Res

  19. NEWMAN-TANCREDI A, Varney MA, McCreary AC
    Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following L-DOPA Administration in Hemi-Parkinsonian Rats.
    Neurochem Res. 2018 Mar 23. pii: 10.1007/s11064-018-2514.
    PubMed     Text format     Abstract available

  20. WANG X, Pang L, Zhang Y, Xu J, et al
    Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease.
    Neurochem Res. 2018 Mar 28. pii: 10.1007/s11064-018-2499.
    PubMed     Text format     Abstract available


    Neurology

  21. BOLLAND MJ, Avenell A, Gamble G, Grey A, et al
    Reader response: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to
    Neurology. 2018;90:627-628.
    PubMed     Text format    

  22. KARAM C, Galetta S
    Editors' note: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to p
    Neurology. 2018;90:627.
    PubMed     Text format    

  23. ROY HA, Aziz TZ, Fitzgerald JJ, Green AL, et al
    Beta oscillations and urinary voiding in Parkinson disease.
    Neurology. 2018 Mar 23. pii: WNL.0000000000005355.
    PubMed     Text format     Abstract available


    Neurosci Lett

  24. HOU Y, Luo C, Yang J, Ou R, et al
    Altered intrinsic brain functional connectivity in drug-naive Parkinson's disease patients with LRRK2 mutations.
    Neurosci Lett. 2018 Mar 19. pii: S0304-3940(18)30215.
    PubMed     Text format     Abstract available

  25. GENG L, Zhang T, Liu W, Chen Y, et al
    miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Neurosci Lett. 2018;675:23-30.
    PubMed     Text format     Abstract available

  26. SADHUKHAN D, Das G, Biswas A, Ghosh S, et al
    Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Neurosci Lett. 2018 Mar 28. pii: S0304-3940(18)30236.
    PubMed     Text format     Abstract available

  27. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Text format     Abstract available


    Neuroscience

  28. HUANG B, Wu S, Wang Z, Ge L, et al
    Phosphorylated alpha-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson Disease Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP.
    Neuroscience. 2018 Mar 25. pii: S0306-4522(18)30217.
    PubMed     Text format     Abstract available

  29. PENKO AL, Streicher MC, Koop MM, Dey T, et al
    Dual-task Interference Disrupts Parkinson's Gait Across Multiple Cognitive Domains.
    Neuroscience. 2018 Mar 22. pii: S0306-4522(18)30212.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: